Chinese Study Challenges Global Cholesterol Guidelines as Low Levels Link to Higher Mortality Risks

New research on Chinese adults shows that very low cholesterol increases cancer and stroke risks, challenging the "lower is better" medical guideline.

By: AXL Media

Published: Apr 28, 2026, 4:51 AM EDT

Source: Information for this report was sourced from EurekAlert!

New Research Challenges Traditional Lipid Management Standards

Medical consensus has long operated on the principle that lower cholesterol is inherently better for heart health, yet a significant new commentary published in Engineering suggests this approach may be dangerously oversimplified. By examining data from over 163,000 Chinese adults and 317,000 UK adults, researchers Jianxin Li and Xiangfeng Lu highlighted a U-shaped association between cholesterol and death. In the Chinese cohort, while high cholesterol remained a threat for heart disease, those with very low levels faced a sharp increase in all-cause mortality, particularly from non-cardiovascular causes.

The Deadly Risks of Falling Below Specific Cholesterol Thresholds

According to the findings, maintaining low-density lipoprotein cholesterol (LDL-C) below 70 mg·dL⁻¹ or total cholesterol below 120 mg·dL⁻¹ carries distinct neurological and oncological dangers. The study observed that these extremely low levels were linked to a higher risk of hemorrhagic stroke, a correlation that persisted regardless of an individual's weight or nutritional status. Furthermore, low cholesterol levels were unexpectedly tied to higher cancer mortality rates, specifically affecting the urological and gastrointestinal systems, suggesting that aggressive lipid reduction might have unintended systemic consequences.

Setting New Population Specific Benchmarks for Optimal Health

The research suggests that the ideal cholesterol window for Chinese adults is higher than current international primary prevention guidelines typically recommend. The study identified optimal thresholds at 200 mg·dL⁻¹ for total cholesterol and 130 mg·dL⁻¹ for LDL-C, which align more closely with what are currently considered borderline-high cutoffs. According to the authors, these figures represent a balance point where the risk of coronary heart disease is minimized without triggering the increased mortality risks associated with the lower end of the spectrum.